Sumitomo Mitsui DS Asset Management Company Ltd purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the fourth quarter, Holdings Channel reports. The firm purchased 47,817 shares of the company’s stock, valued at approximately $4,381,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Farther Finance Advisors LLC raised its stake in HealthEquity by 59.3% during the third quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock worth $37,000 after purchasing an additional 146 shares during the period. Torren Management LLC purchased a new position in HealthEquity during the fourth quarter worth about $40,000. AlphaQuest LLC raised its stake in HealthEquity by 52.2% during the third quarter. AlphaQuest LLC now owns 624 shares of the company’s stock worth $59,000 after purchasing an additional 214 shares during the period. Larson Financial Group LLC raised its stake in HealthEquity by 24.4% during the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after purchasing an additional 123 shares during the period. Finally, IFP Advisors Inc raised its stake in HealthEquity by 1,602.3% during the third quarter. IFP Advisors Inc now owns 749 shares of the company’s stock worth $75,000 after purchasing an additional 705 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.
HealthEquity Price Performance
HealthEquity stock opened at $84.84 on Friday. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $116.65. The company’s 50 day simple moving average is $81.30 and its 200-day simple moving average is $87.78. The company has a market capitalization of $7.17 billion, a price-to-earnings ratio of 34.49, a price-to-earnings-growth ratio of 1.53 and a beta of 0.19. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.27 and a current ratio of 3.27.
Analyst Upgrades and Downgrades
A number of brokerages have commented on HQY. Deutsche Bank Aktiengesellschaft lifted their target price on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research note on Thursday, March 19th. Wall Street Zen downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday. Barclays reduced their target price on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 18th. JPMorgan Chase & Co. reduced their target price on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 18th. Finally, Barrington Research reduced their price target on shares of HealthEquity from $125.00 to $110.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 18th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $111.79.
HealthEquity Company Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Recommended Stories
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
